CP
ADMA icon

CenterBook Partners’s ADMA Biologics ADMA Stock Holding History

CenterBook Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
80,175
-9,292
-10% -$84.7K 0.03% 454
2026
Q1 		$806K Buy
+89,467
New +$1.41M 0.04% 390
2025
Q3 		– Sell
-87,721
Closed -$1.6M – 548
2025
Q2 		$1.6M Buy
+87,721
New +$1.79M 0.09% 258
2022
Q4 		– Sell
-23,779
Closed -$58K – 372
2022
Q3 		$58K Buy
+23,779
New +$57K 0.01% 386

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CenterBook Partners's ADMA Position: Q2 2026 in Review

CenterBook Partners reduced its ADMA Biologics (ADMA) stake by 10% in Q2 2026, selling an estimated $84.7K and leaving 80,175 shares worth $671K. The position accounts for 0.03% of the portfolio, ranked #454.

CenterBook Partners first reported a position in ADMA in Q3 2022 and has held it in 4 quarters since. The position peaked at $1.6M in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • CenterBook Partners held 80,175 shares of ADMA Biologics worth $671K as of Q2 2026.
  • CenterBook Partners sold 9,292 ADMA Biologics shares in Q2 2026, an estimated $84.7K.
  • ADMA Biologics made up 0.03% of CenterBook Partners's portfolio in Q2 2026, its #454 holding.
  • CenterBook Partners first reported a position in ADMA Biologics in Q3 2022 and has held it in 4 quarters since.
  • CenterBook Partners's ADMA Biologics position peaked at $1.6M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.